Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Warner-lambert Company patentsThe following is a sampling of recent Warner-lambert Company patent applications (USPTO Patent Application #, Patent Title) sorted by month.
March 2008 - Warner-lambert Company patents
20080064745 - Androgen modulators
20080058270 - Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
20080058304 - N-hydroxyamide derivatives possessing antibacterial activity
December 2007 - Warner-lambert Company patents
20070293570 - Pharmaceutical uses for alpha2delta ligands
20070281939 - Benzamide inhibitors of the p2x7 receptor
November 2007 - Warner-lambert Company patents
20070276027 - Crystalline forms of [r-(r* ,r*)]-2-(4-fluorophenyl)-beta, -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
20070276039 - Pharmaceutical uses for alpha2delta ligands
20070269511 - Solid pharmaceutical compositions containing pregabalin
October 2007 - Warner-lambert Company patents
20070238749 - Alpha2delta ligands for the treatment of fibromyalgia and other disorders
September 2007 - Warner-lambert Company patents
20070224636 - Pyrrolo[1,2b]pyridazine compounds and their uses
20070225353 - Process for forming amorphous atorvastatin
20070225357 - Formulation for stimulating hair growth
20070219201 - Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders
20070213401 - Pharmaceutical uses for alpha2delta ligands
20070207987 - Androgen modulators
August 2007 - Warner-lambert Company patents
20070203212 - Method of treating osteoarthritis
20070196905 - Stereoselective bioconversion of aliphatic dinitriles into cyano carboxylic acids
20070197500 - Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists
20070197518 - Antibacterial agents
20070197641 - Androgen modulators
20070197642 - Androgen modulators
20070191394 - Antibacterial agents
20070191429 - Ppar activators
20070179120 - Hydroxyl compounds and compositions for cholesterol management and related uses
July 2007 - Warner-lambert Company patents
20070173548 - Malonamic acids and derivatives thereof as thyroid receptor ligands
20070167351 - Peptide/lipid complex formation by co-lyphilization
20070167452 - Therapeutic amide derivatives
20070167506 - Substituted imidazoles
20070161630 - Tricyclic tetrahydroquinoline antibacterial agents
20070161681 - Ether derivatives useful as inhibitors of pde4 isozymes
20070161706 - Pharmaceutical uses for alpha2delta ligands
20070161707 - Pharmaceutical uses for alpha2delta ligands
20070155704 - Ketone compounds and compositions for cholesterol management and related uses
20070155732 - Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
June 2007 - Warner-lambert Company patents
20070149464 - Combination
20070149527 - New treatments for nervous disorders
20070149550 - Substituted arylpyrazoles
20070149564 - Estrogen modulators
20070149615 - Ketone compounds and compositions for cholesterol management and related uses
20070142329 - Benzamide inhibitors of the p2x7 receptor
20070142389 - Piperidine derivatives
20070129388 - Spirocyclic derivatives
20070129409 - Androgen receptor modulators
20070129550 - Amino acids with affinity for the alpha-2-delta-protein
May 2007 - Warner-lambert Company patents
20070122367 - Resorcinol derivatives
20070117850 - Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
20070105870 - Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors
20070105872 - Pyrazine derivatives
April 2007 - Warner-lambert Company patents
20070088037 - Novel imidazole compounds as transforming growth factor (tgf) inhibitors
20070088069 - Novel imidazoles
March 2007 - Warner-lambert Company patents
20070049558 - New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
February 2007 - Warner-lambert Company patents
20070032662 - Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrole-3-carboxylic acid and phenylamide
20070032663 - Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
20070032664 - Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
January 2007 - Warner-lambert Company patents
20070020197 - Preparation of pharmaceutical compositions containing nanoparticles
20070021414 - 1-'2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists
20070015801 - N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
20070010517 - Pharmaceutical salts of reboxetine
December 2006 - Warner-lambert Company patents
20060286622 - Polypeptides exhibiting pde7 activity and their use for selecting compounds which inhibit pde 7 enzyme activity
20060287308 - 3-aminoquinazolin-2,4-dione antibacterial agents
20060287309 - [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
20060287310 - [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
20060287378 - Novel pyrroles and imidazoles
November 2006 - Warner-lambert Company patents
20060270682 - Substituted aryloxymethyl bicyclicmethyl acetamide compounds
20060264626 - Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
20060257340 - Formulation for skin-lightening agents
20060252694 - Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
20060252796 - Androgen modulators
20060247231 - Amide and ester matrix metalloproteinase inhibitors
20060247282 - Methods for using amino acids with affinity for the alpha2delta-protein
20060247291 - Amino acid derivatives
October 2006 - Warner-lambert Company patents
20060241169 - Crystalline forms of [r-(r*.r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1)
20060234997 - Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
20060229281 - Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Warner-lambert Company in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Warner-lambert Company with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
